|
Evaluation of Patients with Known or Suspected Heart Disease Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified health advice, travels to or treatment by using a genuine physician. We are not physicians. Always consult your dr. on Evaluation of Patients with Known or Suspected Heart Disease conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Evaluation of Patients with Known or Suspected Heart Disease Clinical research trials and Evaluation of Patients with Known or Suspected Heart Disease health trials occur in hundreds of cities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectivity of new drugs. The propose of the studies / undertakings is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector companies to locate treatments for all sorts of conditions, including Evaluation of Patients with Known or Suspected Heart Disease. Evaluation of Patients with Known or Suspected Heart Disease Clinical Trials and other clinical trials permit volunteers to acquire medical treatment choices before they are available to the masses. Some times the test subjects obtain professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Evaluation of Patients with Known or Suspected Heart Disease clinical trial. Participants oftentimes recieve the most expert healthcare available for their Evaluation of Patients with Known or Suspected Heart Disease condition. Hazards are a reality, however, and can include extra or frequent physician visits, health risks (potentially life-endangering), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "E" Clinical Trials Conditions > Evaluation of Patients with Known or Suspected Heart Disease  Evaluation of Patients with Known or Suspected Heart Disease
Evaluation of Patients with Known or Suspected Heart Disease
For Condition: Chest Pain,Coronary Disease,Heart Disease,Hypertrophic Cardiomyopathy,Syndrome X
Status: Recruiting
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: In this study researchers will admit and evaluate patients with known or suspected heart disease referred to the Cardiology Branch of the National Heart, Lung, and Blood Institute (NHLBI). Patients participating in this study will undergo a general medical evaluation, including blood tests, urine, examination, chest x-ray and electrocardiogram (EKG). In addition, patients may be asked to have an echocardiogram (ultrasound scan of the heart) and to perform an exercise stress test. These tests are designed to assess the types and causes of patient's heart diseases and to determine if they can participate in other, specific research studies.
Details: The principal mission of the NIH is the conduct of research that elucidates biological mechanisms, pathogenesis, and treatment of disease. Patients with known or suspected cardiovascular diseases are referred to NHLBI cardiologists for consideration of participation in clinical research protocols. However, eligibility for participation is often uncertain from referral information or even after an outpatient evaluation. The purpose of this protocol is to permit inpatient evaluation of patients for whom participation in clinical research protocols is under consideration in order to determine protocol eligibility by means of conventional laboratory and cardiovascular testing.
Eligibility:
Study Type: Observational, Screening
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: The following is a representative list of the types of patient presentations and potential diagnoses eligible for this protocol: 1. Coronary artery disease with effort or rest angina or inducible myocardial ischemia as determined by noninvasive testing. 2. Cardiomyopathies, including restrictive, congestive, and hypertrophic phenotypes. 3. Peripheral artery disease with intermittent claudication or limb-threatening ischemia. 4. Renovascular disease with uncontrolled hypertension, intermittent pulmonary edema, or evidence of ischemic nephropathy. 5. Upper extremity peripheral artery disease. 6. Symptomatic supraventricular and ventricular arrhythmias. EXCLUSION CRITERIA: Pregnancy, for those patients who require catheterization-based diagnostics. Inability to provide informed consent.
Total Enrollment: 9999
Location and Contact Information:
National Heart, Lung and Blood Institute (NHLBI) *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting Patient and Public Liaison Office 1-800-411-1222
Additional Information:
Study ID Numbers: 920189; 92-H-0189
Study Start Date: May 10, 1992
Record last reviewed: March 19, 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001313
Other Coronary Disease Studies:
1. Analysis of Heart Muscle Function in Patients with Heart Disease and Normal Volunteers
2. Evaluation of Patients with Known or Suspected Heart Disease
Related Studies:
Other Coronary Disease Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Evaluation of Patients with Known or Suspected Heart Disease
|
|
|
|
|
|
|
|
